Medical Properties Trust (MPW) stock rose to 200EMA: is it a buy?

April 15, 2024 08:30 AM PDT | By Invezz
 Medical Properties Trust (MPW) stock rose to 200EMA: is it a buy?
Image source: Invezz

Medical Properties Trust (NYSE: MPW) stock price continued its strong recovery on Monday as it surged to a high of $5.32, its highest swing since December 2023. It has been one of the best-performing REIT in the past few weeks as it jumped by over 60% from its lowest point in 2023.

Some progress noted

Medical Properties Trust, the embattled real estate company has made some progress in the past few months as it works to fix its business.

Last month, Steward Healthcare, its biggest tenant, agreed to sell its doctor network to Optum, a company owned by UnitedHealth. The deal is a positive thing for MPW because Steward is its biggest tenant.

As a result, there are signs that Steward will be able to clear some of its outstanding bills to Medical Properties Trust. Still, as I warned recently, Steward is facing substantial risks because of its huge debt and payments to suppliers. 

Medical Properties has also been selling some of its assets to cover its debt. Earlier this month, it completed its sale of facilities to Prime Healthcare in a deal valued at $350 million. It will use these funds to boost its balance sheet and fund operations.

Most recently, the company said that it would sell some of its operations in Utah in a $886 million deal. In a note, the company said:

“Our primary focus remains on accelerating our capital allocation strategy, and we are now confident that we will exceed our initial target of $2.0 billion in liquidity transactions in 2024 based on the valuations achieved on recent transactions and the terms we are actively negotiating for additional transactions.”

Therefore, these actions mean that the company is at a better place than where it was a few months ago. However, it still faces major risks ahead. The biggest risks is Steward Healthcare, which will likely remain under pressure for a while. In addition to being its landlord, MPT is also a big owner of Steward.

The other big risk is that Medical Properties Trust has big maturities coming up in the next few years. Its biggest maturity of $3 billion will be in 2026. That will be a big challenge, especially if interest rates remain at an elevated level.

Medical Properties Trust stock forecast

MPW chart by TradingView

Looking at the daily chart, we see that the MPW share price has rebounded sharply in the past few weeks. The stock soared to a key resistance point at $5.32. As shown above, this price was along the 200-day Exponential Moving Average (EMA).

In most periods, the 200EMA is one of the most important levels. A move above the level would open the possibility of the price forming a golden cross pattern, where it crosses with the 50 EMA. 

Therefore, the outlook for the stock is moderately bullish as the company continues pushing some positive news. More upside will only be confirmed if the stock surges above the 200-day moving average. If this happens, the key point to watch will be at $6.52, its lowest swing on March 24th.

The post Medical Properties Trust (MPW) stock rose to 200EMA: is it a buy? appeared first on Invezz


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next